He received his M.D. and Ph.D. degrees from Northwestern University, Evanston, IL, USA, in 2005; he completed his urology residency at Northwestern University in 2011 and a urologic oncology fellowship at Memorial Sloan-Kettering Cancer in 2012. Meeks’ clinical efforts focus on minimally invasive and open urologic oncology with a particular interest on bladder and prostate cancer. His research interests focus on both the epigenetics and genetic mutations associated with cancer biology. Specifically, he is studying how chromatin remodeling genes play a role in bladder cancer. In addition, he is studying the “driver” mutations found in bladder cancer. In the future, he hopes to develop novel systemic and intravesical therapies to improve survival of patients with bladder cancer.